CycLex® IKKα and β Kinase Assay/Inhibitor Screening Kit (Discontinued)
CycLex IKKα/β Kinase Assay/Inhibitor Screening Kit.
Specifications:
Description
We are sorry for the inconvenience; this product code has been discontinued.
The CycLex Research Products IKK α/β assay/Inhibitor Screening Kit is designed to measure the activities of purified IKKα and IKKβ for the rapid and sensitive evaluation of inhibitors or activators. It can be used for 96 Assays.
| Target: | IKKα and β Kinase |
|---|---|
| Product Type: | Kinase Assay Kit |
| Size: | 96 Assays |
| Research Area / Disease: | Cancer |
Components
- Microplate
- 10X Wash Buffer
- Kinase Buffer
- 20X ATP
- Anti-Phospho-IkappaBbeta S32 Monoclonal Antibody (AS-2E8)
- HRP conjugated Anti-mouse IgG
- Substrate Reagent
- Stop Solution
Citations
- Fakhrudin N et al. Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo. Br J Pharmacol. 171, 1676-86 (2014),
- Harada S, Tominari T, Matsumoto C, Hirata M, Takita M, Inada M, Miyaura C.; Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency. J Pharmacol Sci. 115: 89-93, 2011,
- Heyninck K et al. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ. Biochem Pharmacol. 91, 501-9 (2014),
- Qiu J et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci U S A. 110, 18162-7 (2013)
- Hirata N et al. Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity. Nutrients. 11, pii: E368 (2019)
References
- Ghosh, S., and Karin, M. (2002) Cell 109, S81–S96
- Schmitz, L. M., Bacher, S., and Kracht, M. (2001) Trends Biochem. Sci. 26, 186–190
- Naumann, M., and Scheidereit, C. (1994) EMBO J. 13, 4597–4607
- Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siabenlist, U. (1995) Science 267, 1485–1488
- Chen, Z., Haglen, J., Palombello, V. J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. (1995) Genes Dev. 9, 1586–1597
- DiDonato, J., Mercurio, F., Rosette, C., Wi-Li, J., Suyang, H., Ghosh, S., and Karin, M. (1996) Mol. Cell. Biol. 16, 1295–1304
- Alkalay, I., Yaron, A., Hatzubai, A., Jung, S., Avraham, A., Gerlitz, O., Pashut-Levon, I., and Ben-Neriah, Y. (1995) Mol. Cell. Biol. 15, 1294–1301
- Karin, M., and Ben-Neriah, Y. (2000) Annu. Rev. Immunol. 18, 621–663
- DiDonato, J. A., Mercurio, F., and Karin, M. (1995) Mol. Cell. Biol. 15, 1302–1311
- Scherer, D. C., Brockman, J., Chen, Z., Maniatis, T., and Ballard, D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11259–11263
- Spencer, E., Jiang, J., and Chen, Z. J. (1999) Genes Dev. 13, 284–294
- Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., and Karin, M. (1997) Cell 91, 243–252
- Hu, M. C., and Wang, Y. (1998) Gene (Amst.) 222, 31–40
- DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997) Nature 388, 548–554
- Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennet, B. L., and Rao, A. (1997) Science 278, 860–866
- Rothwarf, D. M., Zandi, E., Natoli, G., and Karin, M. (1998) Nature 395, 297–300
- Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., and Israel, A. (1998) Cell 93, 1231–1240
- Li, Q., Van Antwerp, D., Mercurio, F., Lee, K. F., and Verma, I. M. (1999) Science 284, 321–32535.
- Li, Z. W., Chu, W., Hu, Y., Delhase, M., Deernick, T., Ellisman, M., Johnson, R., and Karin, M. (1999) J. Exp. Med. 189, 1839–1845
- Peters, R. T.; Liao, S.-M. (2000) Maniatis, T. .Mol. Cell 5: 513-522
